ClinicalTrials.gov
ClinicalTrials.gov Menu

First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. (IXOGoo1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01129310
Recruitment Status : Unknown
Verified January 2016 by AHS Cancer Control Alberta.
Recruitment status was:  Active, not recruiting
First Posted : May 24, 2010
Last Update Posted : January 8, 2016
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
AHS Cancer Control Alberta

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : January 2017
  Estimated Study Completion Date : January 2018